Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Hinova Pharmaceuticals Inc. (688302)
- 44.00
- +3.24+7.95%
Market Closed Apr 30 15:00 CST
4.36BMarket Cap-32.26P/E (TTM)
44.20High40.61Low2.35MlotVolume40.95Open40.76Prev Close99.48MTurnover2.37%Turnover RatioLossP/E (Static)99.02MShares71.9852wk High4.21P/B4.36BFloat Cap36.2052wk Low48.91Limit Up99.02MShs Float78.77Historical High32.61Limit Down8.81%Range %22.60Historical Low--Dividend TTM42.42Avg Price835.67KlotAsk--Div Yield TTM1Lot Size1.40MlotBid
Hinova Pharmaceuticals Inc. (688302) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 539,929.20%27M | 6,113.03%25.74M | 5,347.00%19.84M | 4,098.80%13.02M | --5K | --414.35K | --364.24K | --310K | ---- | ---- |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | -95.89%412.48K | -98.72%128.46K | --51.92K | 43.70%19.84M |
| Cash received relating to other operating activities | 340.82%21.58M | 119.30%45.19M | 114.97%34.66M | 81.97%25.98M | 81.72%4.89M | 15.85%20.61M | 45.01%16.12M | 98.26%14.28M | -10.87%2.69M | -21.85%17.79M |
| Cash inflows from operating activities | 891.44%48.58M | 237.45%70.93M | 222.51%54.5M | 164.99%39M | 78.46%4.9M | -44.14%21.02M | -20.14%16.9M | -14.66%14.72M | -9.15%2.75M | -1.54%37.63M |
| Goods services cash paid | 289.49%2.13M | 1,239.76%3.91M | 1,052.35%3.11M | 697.34%2.15M | --547.83K | --292.19K | --270K | --270K | ---- | ---- |
| Staff behalf paid | 60.68%27.53M | 4.14%73.05M | 5.33%57.2M | 1.50%37.33M | -18.69%17.13M | 4.17%70.14M | 4.55%54.31M | 15.00%36.78M | 11.02%21.07M | 25.46%67.34M |
| All taxes paid | -28.84%52.87K | 154.44%1.12M | 99.67%588.07K | 118.95%507.82K | 35.24%74.3K | -1.96%438.45K | -23.11%294.52K | -26.83%231.93K | -35.63%54.94K | 28.24%447.21K |
| Cash paid relating to other operating activities | 33.89%29.99M | -25.87%101.73M | -28.14%73.31M | -39.36%46.43M | -47.03%22.4M | -39.10%137.23M | -39.72%102.01M | -32.73%76.57M | -11.86%42.29M | -24.44%225.35M |
| Cash outflows from operating activities | 48.69%59.71M | -13.60%179.81M | -14.45%134.21M | -24.09%86.43M | -36.68%40.15M | -29.01%208.1M | -29.19%156.88M | -22.08%113.85M | -5.41%63.41M | -16.99%293.14M |
| Net cash flows from operating activities | 68.44%-11.13M | 41.80%-108.88M | 43.06%-79.71M | 52.16%-47.43M | 41.89%-35.25M | 26.78%-187.08M | 30.15%-139.98M | 23.08%-99.14M | 5.24%-60.67M | 18.87%-255.51M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 54.26%540M | -37.01%2.49B | -32.61%1.87B | -30.29%1.3B | -54.54%350.05M | -21.29%3.95B | -29.44%2.78B | -31.73%1.87B | -13.97%770M | -0.04%5.01B |
| Cash received from returns on investments | 50.42%1.41M | -39.86%8.44M | -40.25%5.94M | -45.12%4.06M | -75.59%938.22K | -43.45%14.04M | -50.56%9.94M | -48.61%7.41M | -21.66%3.84M | -15.30%24.83M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --718 | -93.23%147.38 | 47.38%147.38 | ---- | ---- | -90.08%2.18K | -89.28%100 | -72.22%100 | ---- | 21,833.00%21.93K |
| Cash received relating to other investing activities | ---- | --34.74M | --41.4M | --34.74M | --22.89M | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 44.81%541.41M | -36.14%2.53B | -31.15%1.92B | -28.50%1.34B | -51.69%373.87M | -21.40%3.96B | -29.55%2.78B | -31.82%1.87B | -14.01%773.84M | -0.13%5.04B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -69.12%8.23M | -7.44%82.89M | -47.86%57.31M | -47.30%41.5M | -0.83%26.66M | -9.71%89.55M | 42.10%109.93M | 39.97%78.75M | 28.47%26.89M | 43.30%99.18M |
| Cash paid to acquire investments | -27.78%520M | -33.12%2.59B | -28.74%2.07B | -34.99%1.31B | -40.74%720.05M | -23.27%3.87B | -28.04%2.91B | -30.11%2.02B | -0.65%1.22B | -6.45%5.04B |
| Cash paid relating to other investing activities | ---- | ---- | --8.7M | --8.7M | --6.66M | --34.74M | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -29.88%528.23M | -33.12%2.67B | -29.15%2.14B | -35.03%1.36B | -39.34%753.37M | -22.33%3.99B | -28.46%3.01B | -31.11%2.09B | -0.16%1.24B | -5.81%5.14B |
| Net cash flows from investing activities | 103.47%13.18M | -361.82%-139.7M | 4.92%-218.67M | 90.33%-21.4M | 18.92%-379.49M | 69.55%-30.25M | 11.97%-229.99M | 24.42%-221.35M | -36.05%-468.04M | 75.77%-99.33M |
| Financing cash flow | ||||||||||
| Cash from borrowing | ---- | --100M | --100M | --100M | ---- | ---- | ---- | ---- | ---- | -98.33%500K |
| Cash inflows from financing activities | ---- | --100M | --100M | --100M | ---- | ---- | ---- | ---- | ---- | -99.95%500K |
| Borrowing repayment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30.5M |
| Dividend interest payment | --642.5K | --1.24M | 53.45%592.53K | ---- | ---- | ---- | -69.30%386.14K | -67.37%267.49K | -61.13%145.71K | -76.97%904K |
| Cash payments relating to other financing activities | -20.90%965.13K | -13.29%3.52M | -2.07%2.76M | 23.89%1.84M | 85.04%1.22M | -7.61%4.06M | -6.38%2.82M | -19.43%1.49M | -44.44%659.4K | -76.62%4.39M |
| Cash outflows from financing activities | 31.76%1.61M | 17.33%4.76M | 4.62%3.36M | 5.00%1.84M | 51.55%1.22M | -88.67%4.06M | -32.77%3.21M | -34.17%1.75M | -48.44%805.11K | 57.65%35.79M |
| Net cash flows from financing activities | -31.76%-1.61M | 2,447.96%95.24M | 3,112.53%96.64M | 5,694.01%98.16M | -51.55%-1.22M | 88.51%-4.06M | 24.90%-3.21M | 34.17%-1.75M | 48.44%-805.11K | -103.47%-35.29M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -1,154.27%-1.7M | -260.77%-2.29M | -0.64%-1.08M | -160.82%-339.46K | -216.52%-135.44K | -18.35%1.43M | -137.89%-1.08M | -83.97%558.18K | 109.58%116.24K | -77.59%1.75M |
| Net increase in cash and cash equivalents | 99.70%-1.26M | 29.24%-155.64M | 45.81%-202.82M | 109.01%28.99M | 21.40%-416.11M | 43.36%-219.96M | 19.18%-374.25M | 23.58%-321.68M | -28.87%-529.4M | -229.30%-388.38M |
| Add:Begin period cash and cash equivalents | -26.24%437.59M | -27.05%593.23M | -27.05%593.23M | -27.05%593.23M | -27.05%593.23M | -32.32%813.19M | -32.32%813.19M | -32.32%813.19M | -32.32%813.19M | 33.33%1.2B |
| End period cash equivalent | 146.35%436.33M | -26.24%437.59M | -11.06%390.4M | 26.59%622.22M | -37.59%177.12M | -27.05%593.23M | -40.56%438.93M | -37.04%491.51M | -64.11%283.79M | -32.32%813.19M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm